Charmacy Pharmaceutical Co., Ltd.

Equities

2289

CNE1000023D6

Drug Retailers

Market Closed - Hong Kong S.E. 04:08:20 2024-04-26 am EDT 5-day change 1st Jan Change
13.94 HKD -0.29% Intraday chart for Charmacy Pharmaceutical Co., Ltd. +39.68% +7.56%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Charmacy Pharmaceutical 2023 Profit Declines on Lower Asset Disposal Gains MT
Charmacy Pharmaceutical Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 10 July 2024 CI
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Charmacy Pharmaceutical’s Profit to Drop by 45% in 2023 MT
Charmacy Pharmaceutical Meets Minimum Public Float Norms MT
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Charmacy Pharmaceutical Co., Ltd. Approves Final Dividend for the Year Ended 31 December 2022, Payable on 31 July 2023 CI
Charmacy Pharmaceutical Chairman Steps Down MT
Charmacy Pharmaceutical Co., Ltd. Announces Board Changes CI
Charmacy Pharmaceutical Co., Ltd. Announces Ordinary Final Dividend for the Year Ended 31 December 2022, Payable on July 31, 2023 CI
Charmacy Pharmaceutical's Controlling Shareholder Signs Letter of Commitment for Director Appointment; Shares Climb 6% MT
Charmacy Pharmaceutical Co., Ltd. Announces Resignation of Executives CI
Charmacy Pharmaceutical Co., Ltd. Recommends Ordinary Final Dividend for the Year Ended 31 December 2022, Payable on 20 July 2023 CI
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Charmacy Pharmaceutical Renews Loan Provision Deal with Controlling Shareholder MT
Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. completed the acquisition of 32.12963% stake in Charmacy Pharmaceutical Co., Ltd. from a group of shareholders. CI
Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. completed the acquisition of 9% of stake in Charmacy Pharmaceutical Co., Ltd. from Yao Chuanglong. CI
Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. made an offer to acquire additional 32.12963% stake in Charmacy Pharmaceutical Co., Ltd. from a group of shareholders for approximately HKD 250 million. CI
Charmacy Pharmaceutical Forecasts Increase in January-November Net Profit MT
Charmacy Pharmaceutical Co., Ltd. Provides Financial Guidance for the 11 Months Ended 30 November 2022 CI
Charmacy Pharmaceutical to Surrender Land Use Right on Property in China for $22.3 Million MT
Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. agreed to acquire 9% of stake in Charmacy Pharmaceutical Co., Ltd. from Yao Chuanglong for HKD 70.9 million. CI
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Charmacy Pharmaceutical Co., Ltd. Announces Executive Changes CI
Charmacy Pharmaceutical Approves Re-Appointment of Shinewing Certified Public Accountants as the Auditors CI
Chart Charmacy Pharmaceutical Co., Ltd.
More charts
Charmacy Pharmaceutical Co., Ltd. is principally engaged in pharmaceutical products distribution in the People’s Republic of China (the PRC). The products also include healthcare medicine, traditional Chinese drinking tablets, traditional Chinese medicine and medical equipment. Through its subsidiaries, the Company is also engaged in the trading of pharmaceutical products and provision of related services.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 2289 Stock
  4. News Charmacy Pharmaceutical Co., Ltd.
  5. Charmacy Pharmaceutical Meets Minimum Public Float Norms